Long Term Benefits Of A Holistic Approach On Dyslipidaemia Management: Today For A Greater Future

Published: 19 February 2021

  • Views:

    Views Icon 3402

  • Likes:

    Heart Icon 7
  • episode_image
    22m 15s
    Part 1 Maciej Banach Maciej Banach, François Schiele, Carlos Aguiar, Alberto Zambon
Average (ratings)
No ratings
Your rating

Overview

ESC and EAS guidelines brought several important new recommendations.

 

LDL-C control is still the first goal, but a single approach does not fit all patients.

 

Viatris' extensive portfolio can tackle various types of dyslipidaemias from early lifestyle reinforcement to very high-risk conditions. It is this holistic approach that we would like to share for a greater future for your patients.

 

 

This video series is supported by:

Key Learning Objectives

  • How to reach the LDL-C goals of high to very high-risk patients with combination therapy
  • Red yeast rice supplementation
  • How to differentiate EPA from Fenofibrates and how to manage hypertriglyceridemia with Fenofibrates

Faculty

  • Maciej Banach
  • François Schiele
  • Alberto Zambon
  • Carlos Aguiar

More from this programme

Part 1

Low-dosage red yeast rice supplementation in cholesterol control: review and expert opinion by ILEP

1 session
Maciej Banach Watch now

Part 2

Are new LDL-C goals for ACS achievable in real life? How Registries could help?

1 session
François Schiele Watch now

Part 3

Long term benefits of a holistic approach on dyslipidaemia management; today for a greater future

1 session
Carlos Aguiar Watch now

Part 4

Long term benefits of a holistic approach on dyslipidaemia management; today for a greater future

1 session
Alberto Zambon Watch now

Faculty Biographies

Alberto Zambon

Alberto Zambon

Professor Alberto Zambon is Associate Professor of Medicine in the Department of Medicine, DIMED University of Padua School of Medicine, in Italy and also Affiliate Assistant Professor of Medicine in the Division of Endocrinology, Metabolism and Nutrition at the School of Medicine, University of Washington, Seattle in the USA.

 

View full profile